AOD-9604

At the mechanistic level, AOD-9604 is hypothesized to interact with receptors or signaling mediators associated with lipid metabolism in a manner partially overlapping with, yet distinct from, full-length growth hormone. Preclinical data from rodent model studies suggest that the peptide stimulates lipolysis in adipocytes—the enzymatic hydrolysis of stored triglycerides into free fatty acids and glycerol—potentially through engagement of β3-adrenergic receptor pathways or downstream cAMP-dependent mechanisms, without the concurrent activation of IGF-1 production typically observed with intact hGH.

In parallel, AOD-9604 has been investigated for putative inhibitory effects on lipogenesis, the de novo synthesis of fatty acids from non-lipid precursors. In vitro cellular models indicate that the fragment may modulate the activity of lipogenic enzymes, providing researchers with a biochemical handle to study the balance between anabolic fat storage and catabolic fat mobilization at a molecular level. The disulfide bond between Cys residues within the YLRIVQCRSVEGSCGF sequence is regarded as essential for maintaining the active conformation, and reduction of this bond is associated with loss of functional activity in experimental assays, underscoring the importance of tertiary structure in peptide–receptor interactions for this class of compounds.

AOD-9604 is used across a range of in vitro and preclinical research contexts focused on metabolic regulation, adipocyte biology, and growth hormone fragment pharmacology. Representative research application areas include:

• Adipocyte lipolysis assays: Quantification of glycerol and free fatty acid release in cultured adipocyte cell lines (e.g., 3T3-L1) to characterize the peptide's lipolytic potency relative to hGH and other fragments.
• Lipogenesis inhibition studies: Assessment of de novo lipid synthesis rates in hepatocyte or adipocyte models using radiolabeled acetate or glucose incorporation assays.
• β3-Adrenergic receptor signaling research: Investigation of receptor binding affinity, cAMP accumulation, and downstream kinase activation profiles in relevant cell systems.
• Structure–activity relationship (SAR) analysis: Comparative studies using truncated or mutated analogs of AOD-9604 to map the residues critical for metabolic activity within the hGH C-terminal domain.
• Adipogenesis and differentiation modeling: Evaluation of the peptide's influence on transcription factors (e.g., PPARγ, C/EBPα) during preadipocyte differentiation protocols in cell culture.
• Preclinical metabolic phenotyping: Use in rodent obesity or high-fat-diet models to characterize effects on body composition, lipid profiles, and energy expenditure at a research pharmacology level.